SCOPUS 정보 검색 플랫폼

British Journal of Cancer

Volumn 99, Issue 9, 2008, Pages 1555-1556

Did animal offer relevant model for Bevacizumab testing?

(4) Eveno, C a,b Gaujoux, S b Tobelem, G a,b,c Pocard, M a,b,c

a INSERM (France)

b HÔPITAL LARIBOISIÈRE (France)

c UNIVERSITÉ PARIS DESCARTES (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ERLOTINIB; VASCULOTROPIN;

CELL PROLIFERATION; DRUG EFFICACY; DRUG INHIBITION; HEAD AND NECK TUMOR; HUMAN; IRRADIATION; LETTER; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; HEAD AND NECK NEOPLASMS; HUMANS; MICE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 55249109442 PISSN: 00070920 EISSN: 15321827 Source Type: Journal
DOI: 10.1038/sj.bjc.6604693 Document Type: Letter

Times cited : (4)

References (5)

1
- 46349090009
- Combined effects of bevacizumab with erlotinib and irradiation: A preclinical study on a head and neck cancer orthotopic model
- Bozec A, Sudaka A, Fischel JL, Brunstein MC, Etienne-Grimaldi MC, Milano G (2008) Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model. Br J Cancer 99: 93-99
- (2008) Br J Cancer , vol.99 , pp. 93-99
- Bozec, A.¹ Sudaka, A.² Fischel, J.L.³ Brunstein, M.C.⁴ Etienne-Grimaldi, M.C.⁵ Milano, G.⁶

2
- 33847615623
- Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies
- Gerber HP, Wu X, Yu L, Wiesmann C, Liang XH, Lee CV, Fuh G, Olsson C, Damico L, Xie D, Meng YG, Gutierrez J, Corpuz R, Li B, Hall L, Rangell L, Ferrando R, Lowman H, Peale F, Ferrara N (2007) Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proc Natl Acad Sci USA 104: 3478-3483
- (2007) Proc Natl Acad Sci USA , vol.104 , pp. 3478-3483
- Gerber, H.P.¹ Wu, X.² Yu, L.³ Wiesmann, C.⁴ Liang, X.H.⁵ Lee, C.V.⁶ Fuh, G.⁷ Olsson, C.⁸ Damico, L.⁹ Xie, D.¹⁰ Meng, Y.G.¹¹ Gutierrez, J.¹² Corpuz, R.¹³ Li, B.¹⁴ Hall, L.¹⁵ Rangell, L.¹⁶ Ferrando, R.¹⁷ Lowman, H.¹⁸ Peale, F.¹⁹ Ferrara, N.²⁰ more..

3
- 43249095919
- Tumor angiogenesis
- Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358: 2039-2049
- (2008) N Engl J Med , vol.358 , pp. 2039-2049
- Kerbel, R.S.¹

4
- 33644863498
- Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF
- Liang WC, Wu X, Peale FV, Lee CV, Meng YG, Gutierrez J, Fu L, Malik AK, Gerber HP, Ferrara N, Fuh G (2006) Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 281: 951-961
- (2006) J Biol Chem , vol.281 , pp. 951-961
- Liang, W.C.¹ Wu, X.² Peale, F.V.³ Lee, C.V.⁴ Meng, Y.G.⁵ Gutierrez, J.⁶ Fu, L.⁷ Malik, A.K.⁸ Gerber, H.P.⁹ Ferrara, N.¹⁰ Fuh, G.¹¹

5
- 40649128599
- Interaction between bevacizumab and murine VEGF-A: A reassessment
- Yu L, Wu X, Cheng Z, Lee CV, LeCouter J, Campa C, Fuh G, Lowman H, Ferrara N (2008) Interaction between bevacizumab and murine VEGF-A: a reassessment. Invest Ophthalmol Vis Sci 49: 522-527
- (2008) Invest Ophthalmol Vis Sci , vol.49 , pp. 522-527
- Yu, L.¹ Wu, X.² Cheng, Z.³ Lee, C.V.⁴ LeCouter, J.⁵ Campa, C.⁶ Fuh, G.⁷ Lowman, H.⁸ Ferrara, N.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.